Skip to main content
Figure 2 | BMC Medical Genomics

Figure 2

From: Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells

Figure 2

Validation of gene expression changes of the top 10 genes in E-CA-88 cells selected by SAM using qRT-PCR. (A) The relative expression levels of the top 10 genes in clorgyline-treated cells compared to control determined by qRT-PCR. (B) Average gene expression changes determined by qRT-PCR compared to those calculated by SAM. For qPCR, fold changes at each time point were calculated first and the three fold changes were averaged. For SAM, the average of gene expression across the three time points for treated (T) and control (C) was calculated first and then the fold change was determined as T/C.

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us